labroots.com
Cure8 news brief
Why This Matters
Spatial transcriptomics helps map where genes are expressed in intestinal tissue, which can reveal cellular mechanisms of IBD and guide research. Knowing which platforms give more reliable data matters for multicenter studies and for building robust computational tools that could support future diagnostics or research.
Who Should Pay Attention
Researchers working with spatial transcriptomics or single-cell datasets, clinicians involved in IBD research or digital pathology, and patient communities interested in research advances in IBD.
Study Snapshot
Story typeResearch news
Evidence typeEarly laboratory research
Source depthFull source text
What To Know
Researchers built a large cellular atlas of the gastrointestinal tract using single-cell data from over 3 million cells across samples from ulcerative colitis, Crohn's disease, and unaffected individuals. They used this atlas to benchmark two spatial transcriptomics platforms (CosMx and Xenium) for their ability to detect gene expression patterns in tissue.
The study reported that CosMx had higher detection efficiency and greater stability across variable sample preparations compared with Xenium on the panels tested, though performance varied by tissue type and other parameters. The authors plan to expand the dataset and apply computational tools to improve analysis and to train digital pathology/AI models.
Keep In Mind
This is an early-stage, research-focused study benchmarking laboratory platforms and describing a large cellular atlas. It does not change clinical care now. Platform performance can vary by tissue preparation and panel choice, and the researchers intend to expand and refine the dataset and computational methods.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationlabroots.com
Indexed viaBing News
Source typeResearch news
PublishedMay 25, 2026, 8:30 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T ... - Nature
The paper links a Crohn’s disease GWAS signal to reduced LACC1 expression in lymphocytes and to altered immunometabolic function, clarifying a potential mechanism by which genetic variation contributes to IBD risk. It...
Sutterella Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation byspecies.
Researchers identify a gut microbe (Sutterella species) that may worsen intestinal inflammation by blocking AhR-driven IL-22 and IL-17 responses—pathways that help protect the gut lining.
Human gut flagellome profiling using FlaPro reveals TLR5-related phenotype-specific alterations in IBD.
This paper links specific features of the gut bacterial flagellome to TLR5-driven immune activation and reports a disease-associated shift in flagellin profiles in Crohn’s disease and ulcerative colitis, suggesting...